Beaufort Securities reiterated their speculative buy rating on shares of Concepta PLC (LON:CPT) in a research report sent to investors on Tuesday. The firm currently has a GBX 26 ($0.32) price target on the stock.
Concepta PLC (LON:CPT) traded up 2.82% on Tuesday, reaching GBX 18.25. 227,958 shares of the company’s stock were exchanged. Concepta PLC has a 1-year low of GBX 8.25 and a 1-year high of GBX 47.94. The firm’s 50 day moving average is GBX 17.63 and its 200 day moving average is GBX 16.48.
About Concepta PLC
Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.
Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.